Among children newly diagnosed with type 1 diabetes, 48.8% underwent at least one autoantibody test during the six months before or after the diagnosis. Of those tested, 70.1% had at least one ...
Valley fever, also called Coccidioidomycosis, is a fungal infection caused by Coccidioides, a fungus found in soil primarily in dry regions of the United States. People become infected by breathing in ...
The share of adults diagnosed with shingles between 2019 and 2026 rose steeply with age, from about 7 per 10,000 among those born between 2006 and 2008 to 182 per 10,000 among those born between 1968 ...
Among adults with type 2 diabetes, osteoporosis risk was lower for patients prescribed a GLP-1 than for patients who were not prescribed a GLP-1, when compared to a baseline of stable-weight patients ...
The rate of follow-up after an office visit or telehealth visit in the 7, 30, or 90 days after the initial encounter has stayed fairly consistent over the last three years. In most specialties, ...
The incidence of cardiovascular disease (CVD) among adults under 40 has more than doubled since 2010, with rates increasing from 9.4 per 1,000 patients in 2010 to 22.0 per 1,000 patients by 2023.
Key Findings Two new data trackers from Epic Research now provide quarterly snapshots of GLP-1 use and BMI distribution in the U.S. adult population. GLP-1 prescriptions among U.S. adults rose from ...
The self-pay share of encounters rose in all four care settings studied between early 2022 and early 2026, but unevenly: the increase was steepest in the emergency department (5.5% to 7.6%), more ...
More than half of patients are able to maintain weight loss achieved while on semaglutide or liraglutide even a year after discontinuing the medication. However, a portion of patients who stop taking ...
Nebraska and Kansas have the highest rates of Parkinson’s disease among U.S. states studied, with 620 and 596 people diagnosed per 100,000 patients, respectively. Even after adjusting for other ...
In the span of one year, more than 5.8 million duplicate imaging orders were potentially prevented. Nearly 246,000 notifications were generated based on information about imaging studies performed ...
After one year of treatment, patients on any dosage of tirzepatide or injectable semaglutide experienced greater median weight loss than those on any dosage of liraglutide, dulaglutide, or oral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results